INS and obesity due to melanocortin 4 receptor deficiency: However, individuals without obesity had a lower, but significant, reduction in insulin sensitivity by 25.3% (baseline = 29.2 ± 18.4, post: 18.7 ± 14.2; p < 0.05) and significant differences were observed for absolute and percent changes in insulin sensitivity between groups (p < 0.05).